JPRN-UMIN000003785
Completed
Phase 3
Remission maintenance treatment of ulcerative colitis with tacrolimus in azathioprine-intolerant patients: a randomized comparative trial of 5-aminosalicylic acid (5-ASA) monotherapy versus 5-ASA and tacrolimus combination therapy. - A randomized trial of 5-ASA vs. 5-ASA and tacrolimus in maintenance of ulcerative colitis.
Department of Internal medicine, Division of Lower Gastroenterology, Hyogo College of Medicine0 sites80 target enrollmentJuly 1, 2010
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Department of Internal medicine, Division of Lower Gastroenterology, Hyogo College of Medicine
- Enrollment
- 80
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\.A patient who has had hypersensitivity to tacrolimus or ingredients of tacrolimus formulation. 2\.A patient who is in treatment of cyclosporine or bozentan. 3\.A patient who is in treatment of potassium sparing diuretics. 4\.A patient who is pregnant, may be pregnant, breast\-feeds or hopes to be pregnant in the study period. 5\.A patient who is determined as ineligible for a subject in this study by a doctor in charge or others.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Better control and treatment of Ulcerative Colitis (UC) by exploring the universe of microenvironment imposed tissue signatures and their correlates in liquid biopsiesNL-OMON54471Radboud Universitair Medisch Centrum40
Completed
Not Applicable
Antibiotic combination therapy for ulcerative colitisulcerative colitisJPRN-UMIN000017844Shiga University of Medical Science20
Terminated
Not Applicable
Maintaining Remission of Ulcerative Colitis with Faecal Microbiota Transplantation: the MR-UC-FMT Triallcerative ColitisInflammatory Bowel DiseaseUlcerative ColitisOral and Gastrointestinal - Inflammatory bowel diseaseInflammatory and Immune System - Autoimmune diseasesACTRN12622001434785Central Adelaide Local Health Network36
Completed
Not Applicable
Improvement of treatment in ulcerative colitis, severe case and moderate case close to severe case, by early use of infliximabJPRN-UMIN000020402IBD Relapse Prevention Team50
Not yet recruiting
Not Applicable
Treatment of patients with ulcerative colitisHealth Condition 1: null- Ulcerative ColitisHealth Condition 2: K519- Ulcerative colitis, unspecifiedCTRI/2020/06/025914Department of Gastroenterology